2013 so far: the pharmaceutical products making headway in the UK #aspenbio #pharma

Posted On Sep 10 2017 by

#pharmaceutical products # The pharmaceutical products set to make headway in the UK market, 2013 In the last few decades it s been widely reported that the UK s contribution to new pharmaceutical products has steadily declined overall, but last year broke the trend with a record-breaking 39 projects approved. The biggest slump in relatively recent times was in 1985 when only 11 new products went to market, and activity peaked in 1997 and again in 2010 with 34 product launches respectively. A detailed description of activity can be found here. This year, a new wave of medicines to treat …


Big pharmaceutical companies are spending far more on marketing than research – The Washington Post #pharmajobs

Posted On Sep 7 2017 by

#marketing pharmaceuticals # Big pharmaceutical companies are spending far more on marketing than research Prescription drugs are a massive market: Americans spent $329.2 billion on prescription drugs in 2013. That works out to about $1,000 per person in the U.S. as John Oliver pointed out in his show on Sunday night. Oliver also mentioned that nine out of 10 big pharmaceutical companies spend more on marketing than on research. León Markovitz of Dadaviz found and graphed those figures from healthcare research firm GlobalData in the graphic below. The amounts spent on sales and marketing are shown in orange, while the …


Biotech Stocks: 5 Best Performing So Far This Year #pharma #cro

Posted On Aug 21 2017 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …


Biotech Stocks: 5 Best Performing So Far This Year #pharmaceutical #distribution #companies

Posted On Aug 5 2017 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …


2013 so far: the pharmaceutical products making headway in the UK #pharma #bio

Posted On Aug 4 2017 by

#pharmaceutical products # The pharmaceutical products set to make headway in the UK market, 2013 In the last few decades it s been widely reported that the UK s contribution to new pharmaceutical products has steadily declined overall, but last year broke the trend with a record-breaking 39 projects approved. The biggest slump in relatively recent times was in 1985 when only 11 new products went to market, and activity peaked in 1997 and again in 2010 with 34 product launches respectively. A detailed description of activity can be found here. This year, a new wave of medicines to treat …


Biotech Stocks: 5 Best Performing So Far This Year #janssen #pharma

Posted On Jul 13 2017 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …


Big pharmaceutical companies are spending far more on marketing than research – The Washington Post #sankyo #pharma

Posted On Jun 13 2017 by

#marketing pharmaceuticals # Big pharmaceutical companies are spending far more on marketing than research Prescription drugs are a massive market: Americans spent $329.2 billion on prescription drugs in 2013. That works out to about $1,000 per person in the U.S. as John Oliver pointed out in his show on Sunday night. Oliver also mentioned that nine out of 10 big pharmaceutical companies spend more on marketing than on research. León Markovitz of Dadaviz found and graphed those figures from healthcare research firm GlobalData in the graphic below. The amounts spent on sales and marketing are shown in orange, while the …


Big pharmaceutical companies are spending far more on marketing than research – The Washington Post #pharma #mba

Posted On May 30 2017 by

#marketing pharmaceuticals # Big pharmaceutical companies are spending far more on marketing than research Prescription drugs are a massive market: Americans spent $329.2 billion on prescription drugs in 2013. That works out to about $1,000 per person in the U.S. as John Oliver pointed out in his show on Sunday night. Oliver also mentioned that nine out of 10 big pharmaceutical companies spend more on marketing than on research. León Markovitz of Dadaviz found and graphed those figures from healthcare research firm GlobalData in the graphic below. The amounts spent on sales and marketing are shown in orange, while the …


Biotech Stocks: 5 Best Performing So Far This Year #pharmaceutical #manufacturers #association

Posted On May 20 2017 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …


2013 so far: the pharmaceutical products making headway in the UK #app #pharma

Posted On Apr 23 2017 by

#pharmaceutical products # The pharmaceutical products set to make headway in the UK market, 2013 In the last few decades it s been widely reported that the UK s contribution to new pharmaceutical products has steadily declined overall, but last year broke the trend with a record-breaking 39 projects approved. The biggest slump in relatively recent times was in 1985 when only 11 new products went to market, and activity peaked in 1997 and again in 2010 with 34 product launches respectively. A detailed description of activity can be found here. This year, a new wave of medicines to treat …